NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer—An Integrative Multi-Omics Approach

by Christine Bekos, Besnik Muqaku, Sabine Dekan, Reinhard Horvat, Stephan Polterauer, Christopher Gerner, Stefanie Aust, Dietmar Pils
Published 2019-05-01

Proteomic and Metabolomic Analyses Reveal Contrasting Anti-Inflammatory Effects of an Extract of Mucor Racemosus Secondary Metabolites Compared to Dexamethasone.

by Samuel M Meier, Besnik Muqaku, Ronald Ullmann, Andrea Bileck, Dominique Kreutz, Johanna C Mader, Siegfried Knasmüller, Christopher Gerner
Published 2015-01-01

Neutrophil Extracellular Trap Formation Correlates with Favorable Overall Survival in High Grade Ovarian Cancer

by Besnik Muqaku, Dietmar Pils, Johanna C. Mader, Stefanie Aust, Andreas Mangold, Liridon Muqaku, Astrid Slany, Giorgia Del Favero, Christopher Gerner
Published 2020-02-01

Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases

by Nina Zila, Andrea Bileck, Besnik Muqaku, Lukas Janker, Ossia M. Eichhoff, Phil F. Cheng, Reinhard Dummer, Mitchell P. Levesque, Christopher Gerner, Verena Paulitschke
Published 2018-03-01

Reduced LDL-Cholesterol and Reduced Total Cholesterol as Potential Indicators of Early Cancer in Male Treatment-Naïve Cancer Patients With Pre-cachexia and Cachexia

by Hannes Zwickl, Klaus Hackner, Harald Köfeler, Eva-Christina Krzizek, Besnik Muqaku, Dietmar Pils, Dietmar Pils, Hubert Scharnagl, Tora S. Solheim, Tora S. Solheim, Elisabeth Zwickl-Traxler, Martin Pecherstorfer
Published 2020-08-01

Catalase Predicts In-Hospital Mortality after Out-of-Hospital Cardiac Arrest

by Anton Früh, Andrea Bileck, Besnik Muqaku, Raphael Wurm, Benjamin Neuditschko, Henrike Arfsten, Lukas Galli, Lukas Kriechbaumer, Pia Hubner, Georg Goliasch, Gottfried Heinz, Michael Holzer, Fritz Sterz, Christopher Adlbrecht, Christopher Gerner, Klaus Distelmaier
Published 2021-08-01